Paeoniflorin inhibits hepatocellular carcinoma growth by reducing PD-L1 expression

Paeoniflorin inhibits hepatocellular carcinoma growth by reducing PD-L1 expression

Abnormal expression of programmed death-ligand 1 (PD-L1) on cancer cells contributes to immune escape in hepatocellular carcinoma (HCC). Paeoniflorin has been shown to inhibit the growth of HCC; however, whether its inhibitory effect involves reducing PD-L1 expression on HCC cells remains unknown. W...

Full description

Bibliographic Details
Main Authors: Meng Gao, Dongjian Zhang, Cuihua Jiang, Qiaomei Jin, Jian Zhang
Format: Article
Language:English
Published: Elsevier 2023-10-01
Series:Biomedicine & Pharmacotherapy
Subjects:
Hepatocellular carcinoma
Tumor immunotherapy
Paeoniflorin
PD-L1
SOCS3
Online Access:http://www.sciencedirect.com/science/article/pii/S0753332223011083

Internet

http://www.sciencedirect.com/science/article/pii/S0753332223011083

Similar Items